This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
ASCO 2024
ASCO 2024 Bladder Cancer
Conferences
AUA 2014
ASCO 2024
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular and Penile Cancer
Upper Tract Urothelial Carcinoma
Press Releases
ASCO 2024 Bladder Cancer
Viewing 41-59 of 59 articles
#AUA14 - A more extensive pelvic lymph node dissection is associated with improved survival of patients with node-positive prostate cancer - Session Highlights
#AUA14 - Poster: Comparison of toxicity between single and combined modality radiation therapy among low-risk prostate cancer patients
#AUA14 - High incidence of predominant Gleason pattern 4 is associated with low testosterone serum level in localized prostate cancer: An update with 937 patients - Session Highlights
#AUA14 - Session Highlights: Long term follow-up of a large active surveillance cohort
#AUA14 - Multiparametric prostate MRI and MRI/ultrasound fusion biopsy in the follow-up of prostate cancer progression for men on active surveillance - Session Highlights
#AUA14 - Magnetic resonance imaging/ultrasound-fusion biopsy better predicts whole gland pathology on radical prostatectomy compared to standard 12-core biopsy - Session Highlights
#AUA14 - Rectal culture prior to prostate biopsy identifies men at risk for infection: A multi-institutional international collaborative study - Session Highlights
#AUA14 - Multiparametric MRI characteristics of patients upgraded by MRI/ultrasound fusion guided biopsy across PSA-based cutoffs - Session Highlights
#AUA14 - Long term follow up of a large active surveillance cohort - Session Highlights
#AUA14 - Long-term incidence of hematuria, urethral stricture, and bladder cancer following radiation therapy for prostate cancer - Session Highlights
#AUA14 - SPOP mutations in prostate cancer - Session Highlights
#AUA14 - Signaling pathways and implications for cancer immunotherapy - Session Highlights
#AUA14 - Transitioning from drug to therapy development of prostate cancer - Session Highlights
#AUA14 - Comparison of three multi-parametric MRI scoring systems for the detection of prostate cancer on MR/TRUS fusion guided prostate biopsy - Session Highlights
#AUA14 - Prostate cancer partner perspective -- unmet needs - Session Highlights
#AUA14 - The number of systematic biopsy cores raises predominantly the detection of insignificant cancer - Session Highlights
#AUA14 - Visualization of periprostatic nerve fibers before and after radical prostatectomy using diffusion tensor magnetic resonance imaging with tractography - Session Highlights
#AUA14 - Neoadjuvant approaches for high-risk prostate cancer - Session Highlights
#AUA14 - Crossfire: Controversies in Urology - Should the urologist treat hormone resistant prostate cancer? - Session Highlights
1
2
3
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free